These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 31928227)
1. Human ADME for YH12852 using wavelength scanning cavity ring-down spectroscopy (WS-CRDS) after a low radioactivity dose. Kim A; Dueker SR; Dong F; Roffel AF; Lee SW; Lee H Bioanalysis; 2020 Jan; 12(2):87-98. PubMed ID: 31928227 [No Abstract] [Full Text] [Related]
2. Evaluation of cAMS for Lozac'h F; Fahrni S; Maria D; Welte C; Bourquin J; Synal HA; Pearson D; Walles M; Camenisch G Bioanalysis; 2018 Mar; 10(5):321-339. PubMed ID: 29451392 [TBL] [Abstract][Full Text] [Related]
3. Nanotracing and cavity-ring down spectroscopy: A new ultrasensitive approach in large molecule drug disposition studies. Kratochwil NA; Dueker SR; Muri D; Senn C; Yoon H; Yu BY; Lee GH; Dong F; Otteneder MB PLoS One; 2018; 13(10):e0205435. PubMed ID: 30332475 [TBL] [Abstract][Full Text] [Related]
4. Measurements of Carbon-14 With Cavity Ring-Down Spectroscopy. McCartt AD; Ognibene T; Bench G; Turteltaub K Nucl Instrum Methods Phys Res B; 2015 Oct; 361():277-280. PubMed ID: 27065506 [TBL] [Abstract][Full Text] [Related]
5. Laser-based radiocarbon detection in the laboratory: How soon? Murnick DE J Labelled Comp Radiopharm; 2019 Sep; 62(11):768-775. PubMed ID: 31369168 [TBL] [Abstract][Full Text] [Related]
6. Adding value through accelerator mass spectrometry-enabled first in human studies. Seymour MA J Labelled Comp Radiopharm; 2016 Dec; 59(14):640-647. PubMed ID: 27444819 [TBL] [Abstract][Full Text] [Related]
8. Application of liquid chromatography-accelerator mass spectrometry (LC-AMS) to evaluate the metabolic profiles of a drug candidate in human urine and plasma. Prakash C; Shaffer CL; Tremaine LM; Liberman RG; Skipper PL; Flarakos J; Tannenbaum SR Drug Metab Lett; 2007 Aug; 1(3):226-31. PubMed ID: 19356047 [TBL] [Abstract][Full Text] [Related]
9. Biotransformation profiling of [(14)C]ixabepilone in human plasma, urine and feces samples using accelerator mass spectrometry (AMS). Cömezoğlu SN; Ly VT; Zhang D; Humphreys WG; Bonacorsi SJ; Everett DW; Cohen MB; Gan J; Beumer JH; Beijnen JH; Schellens HM; Lappin G Drug Metab Pharmacokinet; 2009; 24(6):511-22. PubMed ID: 20045986 [TBL] [Abstract][Full Text] [Related]
10. Accelerator mass spectrometry in pharmaceutical research and development--a new ultrasensitive analytical method for isotope measurement. Garner RC Curr Drug Metab; 2000 Sep; 1(2):205-13. PubMed ID: 11465084 [TBL] [Abstract][Full Text] [Related]
11. Biodegradability screening of soil amendments through coupling of wavelength-scanned cavity ring-down spectroscopy to multiple dynamic chambers. Bai M; Köstler M; Kunstmann J; Wilske B; Gattinger A; Frede HG; Breuer L Rapid Commun Mass Spectrom; 2011 Dec; 25(24):3683-9. PubMed ID: 22468324 [TBL] [Abstract][Full Text] [Related]
12. Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom. Barker J; Garner RC Rapid Commun Mass Spectrom; 1999; 13(4):285-93. PubMed ID: 10097404 [TBL] [Abstract][Full Text] [Related]
14. The use of accelerator mass spectrometry to obtain early human ADME/PK data. Lappin G; Garner RC Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):23-31. PubMed ID: 16922650 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic analysis of 14C-ursodiol in newborn infants using accelerator mass spectrometry. Gordi T; Baillie R; Vuong le T; Abidi S; Dueker S; Vasquez H; Pegis P; Hopper AO; Power GG; Blood AB J Clin Pharmacol; 2014 Sep; 54(9):1031-7. PubMed ID: 24805288 [TBL] [Abstract][Full Text] [Related]
16. Opportunities in low-level radiocarbon microtracing: applications and new technology. Vuong LT; Song Q; Lee HJ; Roffel AF; Shin SH; Shin YG; Dueker SR Future Sci OA; 2016 Mar; 2(1):FSO74. PubMed ID: 28031933 [No Abstract] [Full Text] [Related]
17. Demonstration of high-precision continuous measurements of water vapor isotopologues in laboratory and remote field deployments using wavelength-scanned cavity ring-down spectroscopy (WS-CRDS) technology. Gupta P; Noone D; Galewsky J; Sweeney C; Vaughn BH Rapid Commun Mass Spectrom; 2009 Aug; 23(16):2534-42. PubMed ID: 19603459 [TBL] [Abstract][Full Text] [Related]
18. Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique. Young G; Ellis W; Ayrton J; Hussey E; Adamkiewicz B Xenobiotica; 2001; 31(8-9):619-32. PubMed ID: 11569529 [TBL] [Abstract][Full Text] [Related]